The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cortical Serotonin 5-HT 2A Receptor Binding and Social Communication in Adults With Asperger’s Syndrome: An in Vivo SPECT Study
Abstract
OBJECTIVE: The cause of autistic spectrum disorder (i.e., autism and Asperger's syndrome) is unknown. The serotonergic (5-HT) system may be especially implicated. However, cortical 5-HT2A receptor density in adults with the disorder has not been examined, to the authors' knowledge. METHOD: The authors investigated cortical 5-HT2A receptor binding in eight adults with Asperger's syndrome and in 10 healthy comparison subjects with single photon emission computed tomography and the selective 5-HT2A receptor ligand 123I iodinated 4-amino-N-[1-[3-(4-fluorophenoxy)propyl]-4-methyl-4-piperidinyl]-5-iodo-2-methoxybenzamide (123I-5-I-R91150). RESULTS: People with Asperger's syndrome had a significant reduction in cortical 5-HT2A receptor binding in the total, anterior, and posterior cingulate; bilaterally in the frontal and superior temporal lobes; and in the left parietal lobe. Also, reduced receptor binding was significantly related to abnormal social communication. CONCLUSIONS: The authors' findings suggest that adults with Asperger's syndrome have abnormalities in cortical 5-HT2A receptor density and that this deficit may underlie some clinical symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
Serotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Serotonin and brain development: role in human developmental diseases
Whitaker-Azmitia, P. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00615-3 · Cited by 506
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Neuroanatomical and neurochemical bases of theory of mind
Abu-Akel, A., & Shamay-Tsoory, S. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.07.012 · Cited by 618
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“Paralleling platelet binding studies, two neuroimaging studies have found decreased 5-HT2 receptor binding: a SPECT study in adults with Asperger’s syndrome (Murphy et al., 2006) and a PET study in parents of children with autism (Goldberg et al., 2009).”
BackgroundPardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510
“Brain imaging studies have demonstrated atypical development in brain serotonin synthesis capacity in children with ASD(37,38) and abnormalities in serotonin receptor 2A binding in the cerebral cortex.(39) Other studies have reported elevated levels of serotonin in peripheral blood but low serotonin levels in the brai…”
BackgroundLesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435
Atypical neural self-representation in autism
Lombardo, M. V., Chakrabarti, B., Bullmore, E. T., Sadek, S. A., Pasco, G., Wheelwright, S. J., Suckling, J., MRC AIMS Consortium, & Baron-Cohen, S. (2010) · Brain · doi:10.1093/brain/awp306 · Cited by 376
Thakkar, K. N., Polli, F. E., Joseph, R. M., Tuch, D. S., Hadjikhani, N., Barton, J. J. S., & Manoach, D. S. (2008) · Brain · doi:10.1093/brain/awn099 · Cited by 367
Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism
Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., Tsuchiya, K. J., Sugihara, G., Iwata, Y., Suzuki, K., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.137 · Cited by 352
Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis
Gabriele, S., Sacco, R., & Persico, A. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.004 · Cited by 346
“Abnormalities in brain 5-HT systems were also reported in ASD, including an altered developmental trajectory of 5-HT turnover (Chugani et al., 1999) and reduced binding of 5-HT receptors and SERT (Murphy et al., 2006; Nakamura et al., 2010).”
BackgroundAntidepressant use during pregnancy and the risk of autism spectrum disorder in children
Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.3356 · Cited by 297
“The capacity of the brain to synthesize serotonin develops atypically in children with ASD,(37) and serotonin receptor 2A binding is altered in the cerebral cortex of these individuals.(38) Strengths of our study include the use of a wellestablished cohort of pregnant women with up to 11 years of follow-up,giving thea…”
BackgroundWilloughby, M., Kupersmidt, J., Voegler-Lee, M., & Bryant, D. (2011) · Developmental Neuropsychology · doi:10.1080/87565641.2010.549980 · Cited by 267
Simms, M. L., Kemper, T. L., Timbie, C. M., Bauman, M. L., & Blatt, G. J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0568-2 · Cited by 183
Neural correlates of reward in autism
Schmitz, N., Rubia, K., van Amelsvoort, T., Daly, E., Smith, A., & Murphy, D. G. M. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036921 · Cited by 153
Self-citationYang, C.-J., Tan, H.-P., & Du, Y.-J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.021 · Cited by 132
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“Abnormalities in brain 5-HT systems have also been described in ASD, including an altered developmental trajectory of 5-HT turnover (Chugani et al, 1999) and decreased radioligand binding to both 5-HT 2A (Goldberg et al, 2009; Murphy et al, 2006) and SERT (Nakamura et al, 2010).”
BackgroundNeurobiological correlates of social functioning in autism
Neuhaus, E., Beauchaine, T. P., & Bernier, R. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.05.007 · Cited by 122
Clinical and anatomical heterogeneity in autistic spectrum disorder: a structural MRI study
Toal, F., Daly, E. M., Page, L., Deeley, Q., Hallahan, B., Bloemen, O., Cutter, W. J., Brammer, M. J., Curran, S., Robertson, D., et al. (2010) · Psychological Medicine · doi:10.1017/s0033291709991541 · Cited by 121
Self-citationBeversdorf, D. Q., & MISSOURI AUTISM SUMMIT CONSORTIUM* (2016) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000351 · Cited by 74
Rigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder
Peters, B., Williams, K. C., Gorrindo, P., Rosenberg, D., Lee, E. B., Levitt, P., & Veenstra-VanderWeele, J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-2009-2 · Cited by 70
“For example, the serotonin system has been implicated in autism (Veenstra-VanderWeele and Blakely 2012; Murphy et al. 2006; Mulder et al. 2004) and in GI disorders and their treatment (Gershon 2013; Ruepert et al.”
BackgroundEl-Ansary, A. K., Bacha, A. B., & Ayahdi, L. Y. A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.06.982 · Cited by 64
Chantiluke, K., Barrett, N., Giampietro, V., Santosh, P., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3837-2 · Cited by 63
“In addition, ASD patients have abnormal 5-HT synthesis (Chugani et al. 1997), 5-HT transporter (Makkonen et al. 2008; Nakamura et al. 2010) and 5-HT2A receptor binding (Murphy et al. 2006).”
BackgroundSelf-citationMurphy, C. M., Deeley, Q., Daly, E. M., Ecker, C., O'Brien, F. M., Hallahan, B., Loth, E., Toal, F., Reed, S., Hales, S., et al. (2012) · Autism Research · doi:10.1002/aur.227 · Cited by 63
Self-citationChantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht365 · Cited by 59
“In addition, in ASD, abnormal 5-HT synthesis (Chugani et al. 1997, 1999), 5-HT transporter (Makkonen et al. 2008; Nakamura et al. 2010), and 5-HT2A receptor binding (Murphy et al. 2006) have also been reported.”
BackgroundInfluentialSelf-citationWalsh, J. J., Llorach, P., Cardozo Pinto, D. F., Wenderski, W., Christoffel, D. J., Salgado, J. S., Heifets, B. D., Crabtree, G. R., & Malenka, R. C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01091-6 · Cited by 56
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Markopoulos, A., Inserra, A., De Gregorio, D., & Gobbi, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749068 · Cited by 46
Developing new pharmacotherapies for autism
Ecker, C., Spooren, W., & Murphy, D. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12113 · Cited by 31
Self-citation
Metadata
- Authors
- Murphy, D. G. M., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., Erlandsson, K., Eersels, J., Kerwin, R., Ell, P., & Travis, M.
- Venue
- American Journal of Psychiatry
- Published
- 2006-05
- Volume
- 163
- Issue
- 5
- Pages
- 934-936
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2106233797
- Cited by
- 181
- References
- 4
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.